Novo Nordisk A/S
NVO
$126.85
$1.060.84%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 12.15B | 10.84B | 9.51B | 8.58B | 7.87B |
| Total Depreciation and Amortization | 1.03B | 1.08B | 983.80M | 899.94M | 901.21M |
| Total Amortization of Deferred Charges | 30.75M | 26.79M | 26.79M | 26.79M | 26.79M |
| Total Other Non-Cash Items | 4.38B | 3.88B | 5.80B | 4.90B | 3.11B |
| Change in Net Operating Assets | -1.75B | -396.76M | -3.59B | -2.42B | -662.42M |
| Cash from Operations | 15.83B | 15.43B | 12.73B | 11.98B | 11.25B |
| Capital Expenditure | -3.74B | -3.07B | -2.65B | -2.14B | -1.70B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -971.82M | -971.82M | -971.82M | -971.82M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.63B | -2.11B | -1.26B | -1.02B | -794.69M |
| Cash from Investing | -6.37B | -6.15B | -4.89B | -4.13B | -3.46B |
| Total Debt Issued | -- | 95.00M | 65.00M | 65.00M | 11.22B |
| Total Debt Repaid | -1.47B | -1.34B | -1.38B | -1.25B | -13.62B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -29.92B | -27.70B | -26.18B | -24.81B | -24.09B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.60B | -4.60B | -3.94B | -3.94B | -3.67B |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 656.00M | 0.00 |
| Cash from Financing | -9.17B | -8.76B | -7.84B | -7.49B | -7.41B |
| Foreign Exchange rate Adjustments | -16.52M | -102.28M | -103.33M | -62.62M | -33.02M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 275.94M | 416.03M | -98.84M | 298.25M | 344.83M |
